Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 Within this work we highlighted one of the first examples of epigenetic-mediated neuroplastic environmental adaptation to psychosocial stress. Indeed, LSD1 operates, upon stress, a transcriptional repression of two key 2-AG hydrolyses, ABHD6 and MAGL. + 1364 word(s) 1364 2020-08-31 11:52:12 |
2 Format correct -75 word(s) 1289 2020-09-02 11:08:50 | |
3 Format correct Meta information modification 1289 2020-09-07 11:12:37 | |
4 Format correct Meta information modification 1289 2020-10-23 11:34:54 | |
5 Format correct -92 word(s) 1197 2020-10-27 09:47:30 |

Video Upload Options

Do you have a full video?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Rusconi, F.; Rubino, T.; Battaglioli, E. Endocannabinoid System. Encyclopedia. Available online: https://encyclopedia.pub/entry/1881 (accessed on 28 March 2024).
Rusconi F, Rubino T, Battaglioli E. Endocannabinoid System. Encyclopedia. Available at: https://encyclopedia.pub/entry/1881. Accessed March 28, 2024.
Rusconi, Francesco, Tiziana Rubino, Elena Battaglioli. "Endocannabinoid System" Encyclopedia, https://encyclopedia.pub/entry/1881 (accessed March 28, 2024).
Rusconi, F., Rubino, T., & Battaglioli, E. (2020, September 01). Endocannabinoid System. In Encyclopedia. https://encyclopedia.pub/entry/1881
Rusconi, Francesco, et al. "Endocannabinoid System." Encyclopedia. Web. 01 September, 2020.
Endocannabinoid System
Edit

Endocannabinoid System (ECS) is widely distributed in the central nervous system (CNS), constituting a complex signaling system that subserves multiple modes of synaptic transmission modulation. It is expressed at some synapses in all brain regions that are important for the processing of anxiety, fear and stress [1].

2-AG Lysine Specific Demethylase 1 (LSD1) Environmental Stress Epigenetics endocannabinoids neuroplasticity homeostasis Stress response ABHD6 MAGL

1. Introduction

In cortical areas (including the cerebral cortex, hippocampus and cortical parts of the amygdala), CB1 receptor is expressed at higher level in cholecystokinin (CCK)-positive GABAergic interneurons, and at lower level in glutamatergic neurons. However, CB1 modulation in glutamatergic neurons has been shown to play an important role in the control of synaptic transmission and neuronal excitability [2][3]. The ECS represents, therefore, a negative synaptic feedback system activated by different neurotransmitters including glutamate, that acts to constrain neurotransmitter activity within stable and adaptive physiological ranges [4]. Since glutamate responses are not limited to synapse but continue into the nucleus where they promote cellular morphological remodeling, hence memory formation, another set of homeostatic mechanisms are devoted to buffer activity-dependent transcription through the rapid modulation of chromatin structure. This is mediated by transient modification of the level or activity of specific epigenetic modifiers [4][5][6].

Notwithstanding homeostatic mechanisms, environmental stress is always potentially toxic, as well as a prominent risk factor for psychiatric disorders [7]. Indeed, even if the majority of individuals can cope with stressful events neutralizing their harmful consequences, a substantial proportion of the human population cannot, being defined as vulnerable and developing long lasting signs of mental illness in response to trauma.

2. ECS and Epigenetic Homeostatic System Cross-Regulation

We recently documented that functional cooperativity between ECS and epigenetic homeostatic system is not limited to an outcome convergence toward limiting synaptic and neuroplastic effects of stress. In particular, a notable feedforward transcriptional mechanism orchestrated by LSD1 is aimed at reinforcing endocannabinoid-mediated suppression of stress-induced glutamate release in the hippocampus. As previously described, endocannabinoid 2-AG is synthesized in dendritic spines in response to glutamate via three main mechanisms of DAG lipase activation: one that is purely calcium-dependent, another that involves metabotropic Gq protein–coupled receptors, and a combined calcium assisted metabotropic mechanism [44]. In order to maintain correct levels of 2-AG concentrations, preventing unwanted inhibition of glutamate release and avoiding desensitization of CB1 receptor, this endocannabinoid is actively degraded by two hydrolases: post-synaptic ABHD6, and presynaptic MAG lipase (MAGL). In this frame, we suggested that in the hippocampus, peak 2-AG concentrations, required to counteract intense glutamatergic responses to social defeat stress are facilitated in mice by LSD1-mediated transcriptional repression of ABHD6 and MAGL [8].

LSD1, whose activity is transiently strengthened via stress-induced decreased levels of dominant negative isoform neuroLSD1, operates a negative modulation of ABHD6 and MAGL transcripts reflecting on protein availability within a homeostasis-demanding window of stress response [8]. Literature is concordant for what concerns 2-AG responses to acute stress, with many works reporting delayed (minutes to hours) 2-AG increase in the hippocampus, amygdala and prefrontal cortex as instrumental to neurotransmitter release regulation in these delayed windows of stress response [9][10][11]. Relevantly, 2-AG signaling in the hippocampus negatively regulates anxiety via positive modulation of DSE, but not inhibitory short-term plasticity [2], foreseeing a role for 2-AG increase as negative regulator of glutamatergic transmission. In general, hippocampal glutamatergic 2-AG signalling appears to be an essential component of adaptation to aversive situations [2].

LSD1-mediated repression of 2-AG degraders ABHD6 and MAGL probably cooperates with such an adaptation, contributing to increasing 2-AG tone in response to acute stress [8]. Indeed, stress-induced LSD1/neuroLSD1 ratio modulation in favor of LSD1 in the hippocampus occurs—requiring de novo transcription and functional modification ­of splicing factors—within hours. Although 2-AG has been shown to raise as early as half an hour after stress [9], LSD1 contribution to enhancing 2-AG levels via a posttranscriptional mechanism could be very relevant in situations of i) prolonged stress, ii) reiterated stress, iii) during the late phases of stress allostasis, all consistent with the duration of 2-AG increase in the same area.

Interestingly, not only LSD1/neuroLSD1 ratio modulation and raise of 2-AG concentration are compatible with their cross-regulation, but these molecular responses to stress also take place within a window characterized by decreased ability of memory formation. This temporary interval of hippocampal inhibition that follows a very limited moment of cognitive enhancement after immediate stress perception, features LTP unresponsiveness in the frame of a widely-accepted protective role against excitotoxicity [12]. This stress-operated hippocampal depression was initially interpreted as an unwanted maladaptive effect of the traumatic event [13], while more recently, such refractory window of memory-consolidation has been endowed with adaptive significance as a behavioral stress-coping strategy. The first inherent hypothesis was that temporary impairment of memory formation could be instrumental to writing, via inhibition of all other potential memories, a perfectly-shaped long-lasting aversive memory of the traumatic event [14][15]. Another possibility we would like to push forward is that this effect could instead hamper memory consolidation of the traumatic event itself, favoring stress resiliency via limiting the formation of a too-vivid and detailed internal image of trauma, which relevantly also represents a core PTSD symptom. Indeed, even if in the immediate early stress-response window, 2-AG increase seems to be important to improve memory formation mediating DSI and hence enhancing memory retention of inhibitory avoidance training [16][17](which is also consistent with the initial phase of cognitive enhancement [12]), in the delayed phase of stress response characterized by hippocampal inhibition—also featuring increased LTD probability likely with endocannabinoid contribution  [18]— 2-AG could turn out to be necessary to DSE, contributing to temporary memory impairment or favoring extinction of the aversive memory instrumentally to resiliency [18]. For a graphical representation of biphasic 2-AG specificity see Figure 1. Thus, stress coping seems to display two opposing requirements the first being an immediate increase in cognition with protective purposes followed soon after, by the second requirement: to decreasing the quality of trauma-related memory traces (temporary memory impairment in Figure 1), again with the protective mean to limiting contextual anxiety arousal. Although biphasic 2-AG activity seems to be very likely it still requires a formal, comprehensive demonstration. A second relevant open question is whether LSD1-mediated MAGL and ABHD6 repression, functionally linked with increasing 2-AG [8] levels could be compatible with cognition enhancement or with a smemorizing effect. Considering the kinetic of LSD1-mediated MAGL and ABHD6 repression, which is delayed compared to initial stress perception, we suggest that LSD1 should be more functionally related with DSE promotion and more entrained with the window of hippocampal unresponsiveness. In this regard we can add that increased LSD1 activity is per se smemorizing [19] also displaying a prominent anxiolytic role in vivo [20].

3. Conclusions

There is no argument with regard to the physical and psychological stress-related nature of neuropsychiatric disorders. Yet, the mechanisms that facilitate disease onset starting from molecular stress responses are elusive. Environmental stress challenges individuals' equilibrium, enhancing homeostatic request in the attempt to steer down arousal-instrumental molecular pathways that underlie hypervigilance and anxiety. A relevant homeostatic pathway is the endocannabinoid system (ECS). In this entry, we summarize recent discoveries unambiguously listing ECS as a stress coping mechanism. We here emphasize a remarkable example of stress-coping network where transcriptional homeostasis subserves synaptic and behavioral adaptation, aiming at reducing psychiatric effects of traumatic experiences.

References

  1. Lutz, B.; Marsicano, G.; Maldonado, R.; Hillard, C.J. The endocannabinoid system in guarding against fear, anxiety and stress. Nat. Rev. Neurosci. 2015, 16, 705–718, doi:10.1038/nrn4036.
  2. Guggenhuber, S.; Romo-Parra, H.; Bindila, L.; Leschik, J.; Lomazzo, E.; Remmers, F.; Zimmermann, T.; Lerner, R.; Klugmann, M.; Pape, H.C.; et al. Impaired 2-AG Signaling in Hippocampal Glutamatergic Neurons: Aggravation of Anxiety-Like Behavior and Unaltered Seizure Susceptibility. Int. J. Neuropsychopharmacol. 2015, 19, doi:10.1093/ijnp/pyv091.
  3. Bluett, R.J.; Báldi, R.; Haymer, A.; Gaulden, A.D.; Hartley, N.D.; Parrish, W.P.; Baechle, J.; Marcus, D.J.; Mardam-Bey, R.; Shonesy, B.C.; et al. Endocannabinoid signalling modulates susceptibility to traumatic stress exposure. Nat. Commun. 2017, 8, 14782, doi:10.1038/ncomms14782.
  4. Rusconi, F.; Battaglioli, E. Acute Stress-Induced Epigenetic Modulations and Their Potential Protective Role Toward Depression. Front. Mol. Neurosci. 2018, 11, 184, doi:10.3389/fnmol.2018.00184.
  5. Borrelli, E.; Nestler, E.J.; Allis, C.D.; Sassone-Corsi, P. Decoding the epigenetic language of neuronal plasticity. Neuron 2008, 60, 961–974, doi:10.1016/j.neuron.2008.10.012.
  6. McEwen, B.S.; Eiland, L.; Hunter, R.G.; Miller, M.M. Stress and anxiety: Structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 2012, 62, 3–12, doi:10.1016/j.neuropharm.2011.07.014.
  7. Bagot, R.C.; Labonté, B.; Peña, C.J.; Nestler, E.J. Epigenetic signaling in psychiatric disorders: Stress and depression. Dialogues Clin. Neurosci. 2014, 16, 281–295.
  8. Longaretti, A.; Forastieri, C.; Gabaglio, M.; Rubino, T.; Battaglioli, E.; Rusconi, F. Termination of acute stress response by the endocannabinoid system is regulated through LSD1-mediated transcriptional repression of 2-AG hydrolases ABHD6 and MAGL. J. Neurochem. 2020, 35, e15000, doi:10.1111/jnc.15000.
  9. Wang, M.; Hill, M.N.; Zhang, L.; Gorzalka, B.B.; Hillard, C.J.; Alger, B.E. Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation. J. Psychopharmacol. 2012, 26, 56–70, doi:10.1177/0269881111409606.
  10. Hill, M.N.; McLaughlin, R.J.; Pan, B.; Fitzgerald, M.L.; Roberts, C.J.; Lee, T.T.; Karatsoreos, I.N.; Mackie, K.; Viau, V.; Pickel, V.M.; et al. Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J. Neurosci. 2011, 31, 10506–10515, doi:10.1523/JNEUROSCI.0496-11.2011.
  11. Evanson, N.K.; Tasker, J.G.; Hill, M.N.; Hillard, C.J.; Herman, J.P. Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology 2010, 151, 4811–4819, doi:10.1210/en.2010-0285.
  12. Diamond, D.M.; Campbell, A.M.; Park, C.R.; Halonen, J.; Zoladz, P.R. The temporal dynamics model of emotional memory processing: A synthesis on the neurobiological basis of stress-induced amnesia, flashbulb and traumatic memories, and the Yerkes-Dodson law. Neural Plast. 2007, 2007, 60803, doi:10.1155/2007/60803.
  13. Schmidt, M.V.; Abraham, W.C.; Maroun, M.; Stork, O.; Richter-Levin, G. Stress-induced metaplasticity: From synapses to behavior. Neuroscience 2013, 250, 112–120, doi:10.1016/j.neuroscience.2013.06.059.
  14. Zoladz, P.R.; Campbell, A.M.; Park, C.R.; Schaefer, D.; Danysz, W.; Diamond, D.M. Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane. Pharmacol. Biochem. Behav. 2006, 85, 298–306, doi:10.1016/j.pbb.2006.08.011.
  15. Cadle, C.E.; Zoladz, P.R. Stress time-dependently influences the acquisition and retrieval of unrelated information by producing a memory of its own. Front. Psychol. 2015, 6, 910, doi:10.3389/fpsyg.2015.00910.
  16. Morena, M.; De Castro, V.; Gray, J.M.; Palmery, M.; Trezza, V.; Roozendaal, B.; Hill, M.N.; Campolongo, P. Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial Memory Retrieval in Rats. J. Neurosci. 2015, 35, 13962–13974, doi:10.1523/JNEUROSCI.1983-15.2015.
  17. Ratano, P.; Petrella, C.; Forti, F.; Passeri, P.P.; Morena, M.; Palmery, M.; Trezza, V.; Severini, C.; Campolongo, P. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation. Neuropharmacology 2018, 138, 210–218, doi:10.1016/j.neuropharm.2018.05.030.
  18. Péterfi, Z.; Urbán, G.M.; Papp, O.I.; Németh, B.; Monyer, H.; Szabó, G.; Erdélyi, F.; Mackie, K.; Freund, T.F.; Hájos, N.; et al. Endocannabinoid-mediated long-term depression of afferent excitatory synapses in hippocampal pyramidal cells and GABAergic interneurons. J. Neurosci. 2012, 32, 14448–14463, doi:10.1523/JNEUROSCI.1676-12.2012.
  19. Wang, J.; Telese, F.; Tan, Y.; Li, W.; Jin, C.; He, X.; Basnet, H.; Ma, Q.; Merkurjev, D.; Zhu, X.; et al. LSD1n is an H4K20 demethylase regulating memory formation via transcriptional elongation control. Nat. Neurosci. 2015, 18, 1256–1264, doi:10.1038/nn.4069.
  20. Rusconi, F.; Grillo, B.; Ponzoni, L.; Bassani, S.; Toffolo, E.; Paganini, L.; Mallei, A.; Braida, D.; Passafaro, M.; Popoli, M.; et al. LSD1 modulates stress-evoked transcription of immediate early genes and emotional behavior. Proc. Natl. Acad. Sci. USA 2016, 113, 3651–3656, doi:10.1073/pnas.1511974113.
  21. Wang, J.; Telese, F.; Tan, Y.; Li, W.; Jin, C.; He, X.; Basnet, H.; Ma, Q.; Merkurjev, D.; Zhu, X.; et al. LSD1n is an H4K20 demethylase regulating memory formation via transcriptional elongation control. Nat. Neurosci. 2015, 18, 1256–1264, doi:10.1038/nn.4069.
  22. Rusconi, F.; Grillo, B.; Ponzoni, L.; Bassani, S.; Toffolo, E.; Paganini, L.; Mallei, A.; Braida, D.; Passafaro, M.; Popoli, M.; et al. LSD1 modulates stress-evoked transcription of immediate early genes and emotional behavior. Proc. Natl. Acad. Sci. USA 2016, 113, 3651–3656, doi:10.1073/pnas.1511974113.
More
Information
Subjects: Clinical Neurology
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : , ,
View Times: 582
Revisions: 5 times (View History)
Update Date: 27 Oct 2020
1000/1000